IN8bio Inc (INAB)
0.3213
+0.01
(+2.78%)
USD |
NASDAQ |
Jan 10, 11:53
IN8bio SG&A Expense (Quarterly): 2.732M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Genprex Inc | 1.566M |
| Ensysce Biosciences Inc | 1.083M |
| Biomarin Pharmaceutical Inc | 253.50M |
| Arbutus Biopharma Corp | 4.537M |
| GlycoMimetics Inc | 4.006M |